Website Header with Language Selector and Dropdowns
Watermark

Flucytosine EP Impurity B


Catalog Number: CL-FCTS-03
CAS No.: 56177-80-1
Mol.F: C6H7FN2O2
Mol.W: 158.1
Inv. Status: Custom Synthesis

Chemical Name: 2-Ethoxy-5-fluoropyrimidin-4(3H)-one.

Country of Origin: India

Product Category: Flucytosine Impurities


Flucytosine EP Impurity B is identified by CAS No. 56177-80-1 and is chemically known as 2-Ethoxy-5-fluoropyrimidin-4(3H)-one.

Flucytosine EP Impurity B is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Flucytosine.

Page Keywords: Buy Flucytosine EP Impurity B | Purchase Flucytosine EP Impurity B | Flucytosine EP Impurity B suppliers | Flucytosine EP Impurity B manufacturers | Flucytosine EP Impurity B price | Flucytosine EP Impurity B Importer | Flucytosine EP Impurity B Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-FCTS-02
CAS No: 51-21-8
Mol Wt: 130.1
Mol F: C4H3FN2O2
Inv. Status: Custom Synthesis
CAT No: CL-FCTS-04
CAS No: 1801-06-5
Mol Wt: 162.5
Mol F: C5H4ClFN2O
Inv. Status: Custom Synthesis
CAT No: CL-FCTS-05
CAS No: 2927-71-1
Mol Wt: 167
Mol F: C4HCl2FN2
Inv. Status: Custom Synthesis
CAT No: CL-FCTS-06
CAS No: (6128-06-9)
Mol Wt: 126.1
Mol F:  C5H6N2O2
Inv. Status: Custom Synthesis
CAT No: CL-FCTS-07
CAS No:  1353100-75-0
Mol Wt: 153.1
Mol F: C6H4FN3O
Inv. Status: Custom Synthesis
CAT No: CL-FCTS-08
CAS No: 726207-85-8
Mol Wt: 158.1
Mol F: C6H7FN2O2
Inv. Status: Custom Synthesis
CAT No: CL-FCTS-10
CAS No: NA
Mol Wt: 238.2
Mol F: C8H7FN6O2
Inv. Status: Custom Synthesis
CAT No: CL-FCTS-11
CAS No: 155-10-2
Mol Wt: 147.5
Mol F: C4H3ClFN3
Inv. Status: Custom Synthesis
CAT No: CL-FCTS-09
CAS No: 1216616-31-7
Mol Wt: 132.1
Mol F: C313CH4FN15N2O
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.